Rachel Eclov

Company: Kriya Therapeutics

Job title: Sr. Director, Ophthalmology Development

Seminars:

Next-Generation Complement-Targeted Gene Therapies in Complement Mediated Diseases 11:40 am

Reviewing Kriya’s gene therapies that precisely target dysregulation and hyperactivity of the complement system Detailing the advantages of using gene therapy to target Geographic Atrophy and other ocular diseases Looking forward to the next steps for KriyaRead more

day: Conference Day Two